期刊文献+

Relationship between gene polymorphisms and prostate cancer risk

Relationship between gene polymorphisms and prostate cancer risk
下载PDF
导出
摘要 Objective: To investigate the relationship between genetic factor and prostate cancer(Pca) risk and the possible cause in it. Methods: The polymorphisms of cytochrome P450 family 17(CYPl7) rs743572, p27 V109 G and androgen receptor(AR) gene CAG repeat length in peripheral blood from 70 cases and 70 controls were detected through the polymerase chain reaction-restriction fragment length polymorphism technique or short tandem repeatpolymerase chain reaction technique. Then, according to the results of case-control study, the recombinant plasmids containing the wild/mutant p27 gene were constructed and transfected Pca LNcap cells. After 24 and 72 h of transfection, the cell proliferative activity was determined by MTT method, cell cycle distribution and apoptosis was detected by flow cytometry, and the expression level of bcl-2, caspase-3 and p27 protein was determined by Western-blot. Results:In three target polymorphisms, only p27 V109 G polymorphism was related to Pca risk(P=0.030, OR=0.202, 95% CI=0.042-0.973). Pca risk of p27-109 G allele was lower than-109 V allele(P=0.006, OR=0.285, 95% CI=0.110-0.737). Cells transfected with wild/mutant p27 gene both showed the higher cells apoptosis rate and the lower cell proliferative activity than mock cells(P<0.05 or 0.01), the regulatory effect of mutant p27 on cell proliferation and apoptosis was stronger than the wild p27(P<0.05). Conclusions: p27-109 G allele that could cause higher p27 protein expression than-109 V allele in LNcap cells, maybe is the protective factor of Pca. Objective: To investigate the relationship between genetic factor and prostate cancer(Pca) risk and the possible cause in it. Methods: The polymorphisms of cytochrome P450 family 17(CYPl7) rs743572, p27 V109 G and androgen receptor(AR) gene CAG repeat length in peripheral blood from 70 cases and 70 controls were detected through the polymerase chain reaction-restriction fragment length polymorphism technique or short tandem repeatpolymerase chain reaction technique. Then, according to the results of case-control study, the recombinant plasmids containing the wild/mutant p27 gene were constructed and transfected Pca LNcap cells. After 24 and 72 h of transfection, the cell proliferative activity was determined by MTT method, cell cycle distribution and apoptosis was detected by flow cytometry, and the expression level of bcl-2, caspase-3 and p27 protein was determined by Western-blot. Results:In three target polymorphisms, only p27 V109 G polymorphism was related to Pca risk(P=0.030, OR=0.202, 95% CI=0.042-0.973). Pca risk of p27-109 G allele was lower than-109 V allele(P=0.006, OR=0.285, 95% CI=0.110-0.737). Cells transfected with wild/mutant p27 gene both showed the higher cells apoptosis rate and the lower cell proliferative activity than mock cells(P&lt;0.05 or 0.01), the regulatory effect of mutant p27 on cell proliferation and apoptosis was stronger than the wild p27(P&lt;0.05). Conclusions: p27-109 G allele that could cause higher p27 protein expression than-109 V allele in LNcap cells, maybe is the protective factor of Pca.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第7期566-570,共5页 亚太热带医药杂志(英文版)
基金 supported by Science and Technology Plan Projects of Henan Province(132102310513)
关键词 PROSTATE cancer CASE-CONTROL study P27 V109G polymorphism LNCAP cells Prostate cancer Case-control study p27 V109G polymorphism LNcap cells
  • 相关文献

参考文献13

  • 1Ethan M. Lange,Aruna V. Sarma,Anna Ray,Yunfei Wang,Lindsey A. Ho,Sarah A. Anderson,Julie M. Cunningham,Kathleen A. Cooney.The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men’s Health Study[J]. Journal of Human Genetics . 2008 (3)
  • 2June M. Chan,Crystal N. Holick,Michael F. Leitzmann,Eric B. Rimm,Walter C. Willett,Meir J. Stampfer,Edward L. Giovannucci.Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)[J]. Cancer Causes & Control . 2006 (2)
  • 3IVANA BALIC,STANLEY T. GRAHAM,DEAN A. TROYER,BETSY A. HIGGINS,BRAD H. POLLOCK,TERESA L. JOHNSON-PAIS,IAN M. THOMPSON,ROBIN J. LEACH.Androgen Receptor Length Polymorphism Associated with Prostate Cancer Risk in Hispanic Men[J]. The Journal of Urology . 2002 (5)
  • 4Hsing Ann W,Chokkalingam Anand P.Prostate cancer epidemiology. Frontiers in bioscience : a journal and virtual library . 2005
  • 5Schaid Daniel J.The complex genetic epidemiology of prostate cancer. Human Molecular Genetics . 2004
  • 6Habuchi T,Liqing Z,Suzuki T,Sasaki R,Tsuchiya N,Tachiki H,Shimoda N,Satoh S,Sato K,Kakehi Y,Kamoto T,Ogawa O,Kato T.Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Research . 2000
  • 7Sheaff R J,Groudine M,Gordon M,et al.Cyclin E-CDK2 is a regulator of p27Kip1. Genes and Development . 1997
  • 8Haiman C A,Stampfer M J,Giovannucci E,Ma J,Decalo N E,Kantoff P W,Hunter D J.The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology . 2001
  • 9Wadelius M,Andersson A O,Johansson J E,Wadelius C,Rane E.Prostate cancer associated with CYP17 genotype. Pharmacogenetics . 1999
  • 10Huang Shu-Pin,Yu Chia-Cheng,Liu Chia-Chu,Wu Tony T,Huang Chun-Hsiung,Wu Ming-Tsang.CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan. Urologia Internationalis . 2008

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部